Application Nr Approved Date Route Status External Links
NDA018676 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Hepatamine® Is Indicated For The Treatment Of Hepatic Encephalopathy In Patients With Cirrhosis Or Hepatitis. Hepatamine® Provides Nutritional Support For Patients With These Diseases Of The Liver Who Require Parenteral Nutrition And Are Intolerant Of General Purpose Amino Acid Injections, Which Are Contraindicated In Patients With Hepatic Coma.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 16 Total)

Name Structure ZINC ID(s)
1. Alanine ALANINE ZINC4658553
2. Arginine ARGININE ZINC1532525
3. Cysteine Hydrochloride CYSTEINE HYDROCHLORIDE ZINC895042
4. Glycine GLYCINE ZINC4658552
5. Histidine HISTIDINE ZINC6661227
6. Isoleucine ISOLEUCINE ZINC3581355
7. Leucine LEUCINE ZINC3645145
8. Lysine Acetate LYSINE ACETATE ZINC1532522
9. Methionine METHIONINE ZINC1532529
10. Phenylalanine PHENYLALANINE ZINC105196
11. Phosphoric Acid
12. Proline PROLINE ZINC895071
13. Serine SERINE ZINC895034
14. Threonine THREONINE ZINC895103
15. Tryptophan TRYPTOPHAN ZINC83315
16. Valine VALINE ZINC895099

Comments